Novel Way to Treat Gonorrhea Identified

A team of researchers have identified a novel lipoprotein that Neisseria gonorrhoeae bacteria use to defeat the human body's first line of immune defense.

A team of researchers have identified a novel lipoprotein that Neisseria gonorrhoeae bacteria use to defeat the human body’s first line of immune defense. The findings of the study are published in PLOS Pathogens.//

The findings are especially important since Neisseria gonorrhoeae is considered a "superbug" due to its resistance to all classes of antibiotics available for treating infections.

Gonorrhea
Gonorrhea is a very common sexually transmitted disease (STD) caused by a bacterium/superbug called Neisseria gonorrhoeae. It is spread during sexual intercourse- vaginal, oral, and anal.

‘Fifty percent of the infected women don’t show any symptoms but can later lead to severe consequences for patient’s reproductive health, premature delivery or miscarriage.’

Gonorrhea, a sexually transmitted disease that results in 78 million new cases worldwide each year, is highly damaging if untreated or improperly treated.

It can lead to endometritis, pelvic inflammatory disease, ectopic pregnancy, epididymitis and infertility. Babies born to infected mothers are at increased risk of blindness.

"The infections very often are silent," said Oregon State University researcher Aleksandra Sikora. "Up to 50 percent of infected women don’t have symptoms, but those asymptomatic cases can still lead to some very severe consequences for the patient’s reproductive health, miscarriage or premature delivery."

The need for better antibiotic therapy, and a vaccine, is pressing. N. gonorrhoeae strains resistant to the last effective treatment options have emerged, and failures in treatment are occurring.

Sikora and her research team at the OSU/OHSU College of Pharmacy and Ann Jerse’s lab at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, collaborated to discover a novel lipoprotein that N. gonorrhoeae uses to defeat the body’s first line of innate immune defense.

Safe Sex
Sex is fun but involves health risks such as sexually transmitted diseases (STDs or unplanned pregnancy specially in those who have multiple partners or in those having unprotected sex.

The body relies on enzymes known as lysozymes that, as their name suggests, thwart bacteria by causing their cell wall to lyse, or break apart. Lysozymes are abundant both in epithelial cells, which make up the tissue on the outside of organs and the inside of body cavities, and in the phagocytic cells that protect the body by ingesting foreign particles and bacteria.

In turn, many gram-negative bacteria characterized by their cell envelope that includes a protective outer membrane have developed ways of defeating lysozymes. Prior to the work by Sikora’s team, however, only one lysozyme-fighting protein had been discovered in the Neisseria genus.

Genital Herpes-Causes-Symptoms–Complications-Diagnosis–Treatment-Prevention
Genital herpes is a sexually- transmitted disease (STD) that affects the genitals.

Now that new targets have been identified, they can be explored as bullseye candidates for new antibiotics or a vaccine if the lysozyme inhibitor can itself be inhibited, then the bacteria’s infection-causing ability is greatly reduced.

Sikora and her collaborators named the new protein SliC, short for surface-exposed lysozyme inhibitor of c-type lysozyme.Studying SliC’s function in culture as well as in a gonorrhea mouse model - mice were infected with N. gonorrhoeae, then checked for SliC expression at one, three and five days - researchers determined the protein was essential to bacterial colonization because of its anti-lysozyme role.

"This is the first time an animal model has been used to demonstrate a lysozyme inhibitor’s role in gonorrhea infection," Sikora said. "Together, all of our experiments show how important the lysozyme inhibitor is. This is very exciting."

Source-Eurekalert